Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 43 Records) |
| Query Trace: Stroke and ABCB1[original query] |
|---|
| Interaction of CYP2C19, P2Y12, and GPIIIa Variants Associates With Efficacy of Clopidogrel and Adverse Events on Patients With Ischemic Stroke. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2016 May . Yi Xingyang, Wang Yanfen, Lin Jing, Cheng Wen, Zhou Qiang, Wang Ch |
| [Relationship between ATP-binding cassette subfamily B member 1 and cytochrome P450 2C19 polymorphisms and the effect of clopidogrel post percutaneous coronary intervention in patients with acute coronary syndrome]. Zhonghua xin xue guan bing za zhi 2016 Apr 44 (4): 309-14. Zhou C F, Ren Y H, Song Y Q, Yi J, Han B S, Xue Q, Fu Z H, Li D |
| Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent. International journal of cardiology 2016 Sep 225 289-295. Sánchez-Ramos Jesús, Dávila-Fajardo Cristina Lucía, Toledo Frías Pablo, Díaz Villamarín Xando, Martínez-González Luis Javier, Martínez Huertas Susana, Burillo Gómez Francisco, Caballero Borrego Juan, Bautista Pavés Alicia, Marín Guzmán Mª Carmen, Ramirez Hernández José Antonio, Correa Vilches Concepción, Cabeza Barrera Jo |
| [Association of ABCB1 gene polymorphisms with aspirin resistance in patients with ischemic stroke]. Zhonghua yi xue za zhi 2016 Dec 96 (47): 3819-3824. Wang Z Y, Wang Y, Sui A H, Dong |
| Left Atrial Appendage Thrombus Formation in a Patient on Dabigatran Therapy Associated With ABCB1 and CES-1 Genetic Defect. Frontiers in pharmacology 2018 9 491. Gu Zhi-Chun, Ma Xiao-Wei, Zheng Xiao-Yuan, Shen Long, Shi Fang-Hong, Li H |
| Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention. Cardiovascular toxicology 2018 May . Mahdieh Nejat, Rabbani Ahmad, Firouzi Ata, Zahedmehr Ali, Hoseinimoghaddam Maryam, Saedi Sedigheh, Sanati Hamidreza, Basiri Hosseinali, Noohi Feridoun, Rabbani Bahareh, Maleki Maj |
| Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke. Pharmacogenomics and personalized medicine 2018 4 11 43-49. Kryukov Alexander Valerevich, Sychev Dmitry Alekseevich, Andreev Denis Anatolevich, Ryzhikova Kristina Anatolievna, Grishina Elena Anatolievna, Ryabova Anastasia Vladislavovna, Loskutnikov Mark Alekseevich, Smirnov Valeriy Valerevich, Konova Olga Dmitrievna, Matsneva Irina Andreevna, Bochkov Pavel Olegovi |
| Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes: The PHARMCLO Trial. Journal of the American College of Cardiology 2018 Feb . Notarangelo Francesca Maria, Maglietta Giuseppe, Bevilacqua Paola, Cereda Marco, Merlini Piera Angelica, Villani Giovanni Quinto, Moruzzi Paolo, Patrizi Giampiero, Malagoli Tagliazucchi Guidantonio, Crocamo Antonio, Guidorossi Angela, Pigazzani Filippo, Nicosia Elisa, Paoli Giorgia, Bianchessi Marco, Comelli Mario Angelo, Caminiti Caterina, Ardissino Die |
| Effect of ABCB1 Genotypes on the Pharmacokinetics and Clinical Outcomes of New Oral Anticoagulants: A Systematic Review and Meta-analysis. Current pharmaceutical design 2018 24 (30): 3558-3565. Xie Qiufen, Xiang Qian, Mu Guangyan, Ma Lingyue, Chen Shuqing, Zhou Shuang, Hu Kun, Zhang Zhuo, Cui Yimin, Jiang J |
| Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study. Scientific reports 2018 1 8 (1): 1229. Joo Hyung Joon, Ahn Sung Gyun, Park Jae Hyoung, Park Ji Young, Hong Soon Jun, Kim Seok-Yeon, Choi WoongGil, Gwon HyeonCheol, Lim Young-Hyo, Kim Weon, Kang Woong Chol, Cho Yun-Hyeong, Kim Yong Hoon, Yoon JungHan, Shin WonYong, Hong Myeong-Ki, Garg Scot, Jang Yangsoo, Lim Do-S |
| Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care. Journal of thrombosis and thrombolysis 2019 Sep . Gulilat Markus, Keller Denise, Linton Bradley, Pananos A Demetri, Lizotte Daniel, Dresser George K, Alfonsi Jeffrey, Tirona Rommel G, Kim Richard B, Schwarz Ute |
| Association of SLCO1B1 and ABCB1 Genetic Variants with Atorvastatin-induced Myopathy in Patients with Acute Ischemic Stroke. Current pharmaceutical design 2019 Jul . Zhang Limin, Lv Hong, Zhang Qian, Wang Dongzhi, Kang Xixiong, Zhang Guojun, Li Xinga |
| [Genetic and non-genetic factors of laboratory resistance to clopidogrel in patients with ischemic stroke]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2019 119 (3. Vyp. 2): 45-52. Sychev D A, Shprakh V V, Kitaeva E Yu, Mirzaev K B, Mickhalevich I |
| Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial. JAMA neurology 2019 Feb . Pan Yuesong, Chen Weiqi, Wang Yilong, Li Hao, Johnston S Claiborne, Simon Tabassome, Zhao Xingquan, Liu Liping, Wang David, Meng Xia, Wang Yongjun, |
| Association of ABCB1 C3435T Polymorphism with Echocardiographic Index Among Patients with Atherosclerotic Ischemic Stroke and Transient Ischemic Attack. Journal of molecular neuroscience : MN 2020 May . Wang Long, Yang Linfei, Zhang Jing, Xu Mingsheng, Han Yulong, Yang Yuwen, Sun Guilan, Zhang Kezhi, Sun Jiany |
| Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2020 4 26 1076029620909154. Rojo Mario, Roco Angela Margarita, Suarez Marcelo, Lavanderos Maria Alejandra, Verón Gabriel, Bertoglia Maria Paz, Arredondo Annabella, Nieto Elena, Rubilar Juan Carlos, Tamayo Francisca, Cruz Daniela, Muñoz Jessica, Bravo Gabriela, Salas Patricio, Mejías Fanny, Véliz Paulo, Godoy Gerald, Varela Nelson Miguel, Llull G, Quiñones Luis Ab |
| CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban. Pharmacogenomics and personalized medicine 2020 3 13 29-37. Sychev D A, Baturina O A, Mirzaev K B, Rytkin E, Ivashchenko D V, Andreev D A, Ryzhikova K A, Grishina E A, Bochkov P O, Shevchenko R |
| [Study on the relationship between ABCB1 gene polymorphism and hemorrhage risk after thrombolysis of cerebral ischemic stroke in Shangqiu area]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2021 7 55 (7): 884-889. Jiang K, Yang Q S, Zhang Y, Li C Y, Fang Y, Cao F, Zhao |
| Combined influence of ABCB1 genetic polymorphism and DNA methylation on aspirin resistance in Chinese ischemic stroke patients. Acta neurologica Belgica 2021 Jun . Xu Liyan, Wang Y |
| Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients. Frontiers in pharmacology 2022 12 13 1007113. Campos-Staffico Alessandra M, Dorsch Michael P, Barnes Geoffrey D, Zhu Hao-Jie, Limdi Nita A, Luzum Jasmine |
| Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events. Frontiers in genetics 2022 10 13 982955. Attelind Sofia, Hallberg Pär, Wadelius Mia, Hamberg Anna-Karin, Siegbahn Agneta, Granger Christopher B, Lopes Renato D, Alexander John H, Wallentin Lars, Eriksson Nicl |
| ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban. Drug design, development and therapy 2023 8 17 2513-2522. Hamin Kim, Tae-Jin Song, Jeong Yee, Dong-Hyeok Kim, Junbeom Park, Hye Sun Gw |
| The Effect of the ABCB1(MDR-1) C3435T Polymorphism in Turkish Patients with Aspirin Resistance in Acute Ischemic Stroke. Translational stroke research 2023 7 . Emrah Yurek, Burcu Genc Yavuz, Esra Guzel Tanoglu, Erdem Gurkas, Ibrahim Altundag, Burhanettin Yalcinkaya, Erdal Y?lmaz, Sahin Col |
| Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes. Pharmacogenomics and personalized medicine 2023 10 16 901-909. Ismail Mouhrach, Laila Bouguenouch, Adil Kamal, Abbassi Meriame, Nada El Khorb, Mohammed El Azami El Idrissi, Hafid Akoudad, Hicham Bekka |
| The impact of ABCB1, CYP3A4 and CYP3A5 gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation. Drug metabolism and personalized therapy 2024 6 . Alena I Skripka, Pavel M Krupenin, Olga N Kozhanova, Anna A Kudryavtseva, Ludmila V Fedina, Kristina A Akmalova, Pavel O Bochkov, Anastasiya A Sokolova, Dmitriy A Napalkov, Dmitriy A Sych |
| The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study. BMC neurology 2024 6 24 (1): 216. Rakhmad Hidayat, Rizqi Amanda Nabilah, Marc Fisher, Tiara Aninditha, Mohammad Kurniawan, Riwanti Estiasari, Luh Ari Indrawati, Ahmad Yanuar Safri, Taufik Mesiano, Al Rasyid, Salim Harr |
| Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants. Therapeutic advances in cardiovascular disease 2024 5 18 17539447241249886. Ayan Abdrakhmanov, Aizhana Shaimerdinova, Zhanasyl Suleimen, Svetlana Abildinova, Rustam Albayev, Gulnar Tuyakova, Elena Rib, Akmaral Beysenbayeva, Gulden Kabduyeva, Makhabbat Bekbossyno |
| The associations of candidate gene polymorphisms with aspirin resistance in patients with ischemic disease: a meta-analysis. Human genomics 2024 12 18 (1): 135. Chun-Xing Li, Li-Chaoyue Sun, Yu-Qiao Wang, Tian-Tian Liu, Jin-Rui Cai, Hua Liu, Zhao Ren, Zhanmiao |
| Bleeding Events Associated with Rivaroxaban Therapy in Naive Patients with Nonvalvular Atrial Fibrillation: A Longitudinal Study from a Genetic Perspective with INR Follow-Up. Medicina (Kaunas, Lithuania) 2024 10 60 (10): . Nur Ul Ain, Niaz Ali, Abid Ullah, Shakir Ullah, Shujaat Ahm |
| Correlation between ABCB1 and OLIG2 polymorphisms and the severity and prognosis of patients with cerebral infarction. Open medicine (Warsaw, Poland) 2024 1 19 (1): 20230841. ChaoYing Liang, CuiYan Huang, ZhenRu Nong, SongLiang Li, MinShi Lin, ZuYe Q |
- Page last reviewed:Feb 1, 2024
- Content source: